Acute myocardial infarction and cardiogenic shock: Pharmacologic and mechanical hemodynamic support pathways

Tobias Graf, Steffen Desch, Ingo Eitel, Holger Thiele*

*Corresponding author for this work
3 Citations (Scopus)

Abstract

Cardiogenic shock (CS) is still the predominant cause of in-hospital death in patients with acute myocardial infarction, although mortality has been reduced in recent years. Early percutaneous coronary intervention and coronary artery bypass grafting are causal therapies implemented in CS, supported by catecholamines, fluids, intra-aortic balloon pumping, and also active percutaneous assist devices. There is only limited evidence from randomized studies of any of these treatments in CS, except for early revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This review will present treatment pathways of CS complicating acute myocardial infarction, with a major focus on revascularization, intensive care unit treatment, and mechanical support devices.

Original languageEnglish
JournalCoronary Artery Disease
Volume26
Issue number6
Pages (from-to)535-544
Number of pages10
ISSN0954-6928
DOIs
Publication statusPublished - 01.01.2015

Research Areas and Centers

  • Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

  • 205-12 Cardiology, Angiology

Fingerprint

Dive into the research topics of 'Acute myocardial infarction and cardiogenic shock: Pharmacologic and mechanical hemodynamic support pathways'. Together they form a unique fingerprint.

Cite this